Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).
D000818:Animals; D002470:Cell Survival; D002478:Cells, Cultured; D002999:Clone Cells; D003561:Cytarabine / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D004357:Drug Synergism; D005663:Furans / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D007042:Hypoxanthines / Q000378:metabolism; D007942:Leukemia, Experimental / Q000378:metabolism; D008727:Methotrexate / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D010710:Phosphates / Q000032:analysis / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D005663:Furans; D007042:Hypoxanthines; D010710:Phosphates; D003561:Cytarabine; D014316:Tritium; D012694:Serine; D008727:Methotrexate